Sensorium Therapeutics Announces Appointment of Veteran Biotech Executive Alexandra Glucksmann, Ph.D., as CEO as the Company Progresses Toward the Clinic

Glucksmann succeeds current Sensorium CEO and Co-Founder Dick Simon, who will transition to an advisory role and continue to serve on the Board of Directors The company announces a $3 million National Institutes of Health/National Institute on Aging gra... Biopharmaceuticals, Personnel Sensorium Therapeutics, anxiety, depression
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news